Search research articles
Contact Us
Filters
Showing results (781-790 of 919) with videos related to
Page
of 92
Sort By:
Journal of Medicinal Chemistry
|
January 14, 2014
Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition
Dean G Brown, Peter R Bernstein, Andrew Griffin, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
September 20, 2022
Urinary total conjugated 3-bromotyrosine, asthma severity, and exacerbation risk
Zeneng Wang, Weiling Xu, Suzy A A Comhair, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 14, 1997
An evaluation of colchicine as an alternative to inhaled corticosteriods in moderate asthma. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network
J E Fish, S P Peters, C V Chambers, et al.
American Journal of Respiratory Cell and Molecular Biology
|
December 19, 2024
Multicohort Analysis of Bronchial Epithelial Cell Expression in Healthy Subjects and Patients with Asthma Reveals Four Clinically Distinct Clusters
Ian Lee, Ananthakrishnan Ganesan, Laurynas Kalesinskas, et al.
The Journal of Allergy and Clinical Immunology
|
February 16, 2023
Bronchial epithelial cell transcriptional responses to inhaled corticosteroids dictate severe asthmatic outcomes
Scott P Ginebaugh, Matthias Hagner, Anuradha Ray, et al.
The Journal of Allergy and Clinical Immunology
|
February 12, 2021
Quantitative CT metrics are associated with longitudinal lung function decline and future asthma exacerbations: Results from SARP-3
James G Krings, Charles W Goss, Daphne Lew, et al.
The Lancet. Respiratory Medicine
|
June 11, 2016
Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts
Michael C Peters, Kelly Wong McGrath, Gregory A Hawkins, et al.
The Journal of Allergy and Clinical Immunology
|
March 11, 2018
Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids
Michael C Peters, Sheena Kerr, Eleanor M Dunican, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 16, 2025
Evaluating the Impact of the COVID-19 Pandemic on Pediatric Asthma Incidence
Ashley L Devonshire, Theresa Guilbert, Cindy S Bauer, et al.
Pediatric Pulmonology
|
August 20, 2019
Clinical significance of the bronchodilator response in children with severe asthma
Andrea M Coverstone, Leonard B Bacharier, Bradley S Wilson, et al.
Page
of 92
Search research articles
Search
Showing results (781-790 of 919) with videos related to
Sort By:
Page
of 92
Journal of Medicinal Chemistry
|
January 14, 2014
Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition
Dean G Brown, Peter R Bernstein, Andrew Griffin, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
September 20, 2022
Urinary total conjugated 3-bromotyrosine, asthma severity, and exacerbation risk
Zeneng Wang, Weiling Xu, Suzy A A Comhair, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 14, 1997
An evaluation of colchicine as an alternative to inhaled corticosteriods in moderate asthma. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network
J E Fish, S P Peters, C V Chambers, et al.
American Journal of Respiratory Cell and Molecular Biology
|
December 19, 2024
Multicohort Analysis of Bronchial Epithelial Cell Expression in Healthy Subjects and Patients with Asthma Reveals Four Clinically Distinct Clusters
Ian Lee, Ananthakrishnan Ganesan, Laurynas Kalesinskas, et al.
The Journal of Allergy and Clinical Immunology
|
February 16, 2023
Bronchial epithelial cell transcriptional responses to inhaled corticosteroids dictate severe asthmatic outcomes
Scott P Ginebaugh, Matthias Hagner, Anuradha Ray, et al.
The Journal of Allergy and Clinical Immunology
|
February 12, 2021
Quantitative CT metrics are associated with longitudinal lung function decline and future asthma exacerbations: Results from SARP-3
James G Krings, Charles W Goss, Daphne Lew, et al.
The Lancet. Respiratory Medicine
|
June 11, 2016
Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts
Michael C Peters, Kelly Wong McGrath, Gregory A Hawkins, et al.
The Journal of Allergy and Clinical Immunology
|
March 11, 2018
Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids
Michael C Peters, Sheena Kerr, Eleanor M Dunican, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 16, 2025
Evaluating the Impact of the COVID-19 Pandemic on Pediatric Asthma Incidence
Ashley L Devonshire, Theresa Guilbert, Cindy S Bauer, et al.
Pediatric Pulmonology
|
August 20, 2019
Clinical significance of the bronchodilator response in children with severe asthma
Andrea M Coverstone, Leonard B Bacharier, Bradley S Wilson, et al.
Page
of 92